相关实验视频
Updated: Jul 1, 2025

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.1K
患有白血病的儿童的化疗相关症状:隐性分析和网络分析的应用
Meixiang Wang1,2, Jia Fang3, Xiaoyan Hu1
1Department of Nursing, Guangzhou Women and Children's Medical Center, No.9 Huasui Road, Guangzhou, 510620, China.
概括
患有白血病的儿童的化疗呈现出各种症状. 识别四个不同的症状子组可以改善个性化护理和症状管理,以获得更好的结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 症状管理 症状管理
- 健康心理学 心理健康心理学
背景情况:
- 患有白血病的儿童往往会经历各种与化疗相关的症状.
- 有效的症状管理需要理解症状的异质性.
- 识别不同的患者子组对于定制干预至关重要.
研究的目的:
- 在儿童白血病患者中识别化疗相关症状的子组.
- 描述每个已识别的症状子组的独特特征.
- 为患有白血病的儿童提供个性化的症状管理策略.
主要方法:
- 500名患有白血病的儿童的横截面调查.
- 利用潜质分析来识别症状子组.
- 采用多重回归和网络分析来进行子组表征.
主要成果:
- 确定了四种不同的症状概况:低症状负担 (26.2%),中度过渡性 (14.8%),中度心理 (35.6%) 和高症状负担 (23.4%).
- 较低的护理人员教育,收入,自付费用和特定的治疗阶段 (诱导,巩固) 与较高的症状负担相关.
- 恶心在低/中等概况中占据了中心地位",不像我自己"在中等心理概况中,在高症状负担概况中令人担忧.
结论:
- 在儿童白血病患者中,化疗诱导的症状是异质的.
- 确定了四个不同的亚组,症状严重程度和特征各不相同.
- 识别这些子组可以实现个性化护理,提高干预的有效性,并减少症状负担.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K

